MIR5693

Across TCGA pan-cancer cohorts, MIR5693 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MIR5693 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher MIR5693 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR5693 expression acts as an unfavorable survival marker, although some lineages such as CHOL and STAD show a favorable association.

MESO, ACC, and BLCA are the cancer types where MIR5693 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	IV	0.056	0.640	<.001	126	view →
ACC	OS	Tertile	All	0.375	0.857	<.001	63	view →
BLCA	DFS	Tertile	III,IV	0.284	0.591	<.001	54	view →
CHOL	DFS	Tertile	II,III,IV	0.754	0.225	.026	30	view →
UCEC	DFS	Tertile	All	0.793	0.903	.001	24	view →
SKCM	DFS	Tertile	III,IV	0.379	0.674	.014	21	view →
LGG	OS	Tertile	All	0.275	0.535	<.001	21	view →
STAD	OS	Quartile	All	0.767	0.623	.019	19	view →
LUAD	OS	Tertile	II,III,IV	0.940	0.687	.023	18	view →
READ	OS	Tertile	III,IV	1.000	0.396	.013	18	view →
KIRC	DFS	Tertile	II,III,IV	0.879	0.765	.024	11	view →
PAAD	DFS	Tertile	All	0.726	0.459	.013	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MIR5693–MESO (OS)

Open the MESO breakdown →